With the rapid advancement and technical iteration of the global healthcare industry, international presence has become the core engine for the sustainable growth of leading medical device enterprises. Hangzhou Singclean Medical Products Co., Ltd. (Singclean Medical), a globally recognized leader in medical biomaterials and In Vitro Diagnostics (IVD), has announced its upcoming participation in two world-class healthcare exhibitions from June to July 2026: WHX Miami (World Health Expo Miami 2026) in the United States and WHX Bangkok (World Health Expo Bangkok 2026) in Thailand.
Singclean Medical will seize these opportunities to demonstrate its latest achievements under the dual-wheel drive of "Medical Biomaterials" and "In Vitro Diagnostics," cordially inviting global partners to explore new horizons in medical healthcare.
Stop 1: Highlighting the Americas — WHX Miami 2026
Serving as the most prominent trade platform connecting North and Latin American healthcare industries, WHX Miami 2026 (formerly known as FIME) will take place from June 17 to 19, 2026, at the Miami Beach Convention Center in Miami Beach, Florida.
At this exhibition, Singclean Medical will display its high-end medical biomaterials portfolio at Booth F44, highlighting advanced clinical solutions in medical aesthetics, orthopedics, and surgical hemostasis.
Featured Products & Highlights:
Singderm® Mono-phasic Dermal Filler (HA Filler)
● : A mono-phasic hyaluronic acid dermal filler containing lidocaine. It has earned wide global acclaim for its superb safety profile, natural-looking aesthetic results, and highly comfortable injection experience.
Singjoint® Medical Sodium Hyaluronate Gel (HA Gel for Bone Joint)
● : A viscoelastic solution designed for joint lubrication to relieve osteoarthritis pain and improve joint mobility, helping patients restore their quality of life.
Absorbable Hemostatic Powder
● : An innovative plant-based hemostatic material developed independently by Singclean. It stops surgical bleeding rapidly and safely, and can be fully absorbable by the body within days without toxic side effects, significantly enhancing the safety of surgical procedures.
Compliance & Quality Standards:
Singclean's products have successfully obtained rigorous regulatory approvals from worldwide authorities, including ANVISA (Brazil), COFEPRIS (Mexico), DIGEMID (Peru), CE(MDR) (EU), MHRA (UK), and HSA (Singapore). This certifies that Singclean's products adhere to the highest international quality standards, facilitating localized distribution and clinical trust in North America, Latin America, Europe, and Asia.
Date : June 17th - 19th, 2026
Venue: Miami Beach Convention Center, Miami Beach, Florida, USA
Singclean Booth: F44
Stop 2: Driving Rapid Diagnostics in Southeast Asia — WHX Bangkok 2026
Following the Miami exhibition, Singclean's global layout will shift to the dynamic Southeast Asian market. From July 8 to 10, 2026, WHX Bangkok & Labs Bangkok 2026 will be held at the prestigious Queen Sirikit National Convention Center (QSNCC) in Bangkok, Thailand.
Addressing the rising demand for convenient and highly efficient rapid diagnostics in Southeast Asia, Singclean Medical will exhibit under the banner "Your Trusted Partner for Rapid Test Kit in Southeast Asia" at Booth K23.
Featured Products & Highlights:
● HIV-1/2 Antibody Urine Test Kit: A revolutionary diagnostic tool developed by Singclean for infectious disease screening. Unlike traditional blood tests, this kit utilizes non-invasive urine sampling, making it entirely painless, safe, and highly confidential. Users can perform high-accuracy HIV screening privately and anonymously at home, receiving reliable results in just 15 minutes. This non-invasive and highly private testing method perfectly aligns with the urgent public health and screening needs in Southeast Asia.
● Comprehensive Rapid Diagnostics (POCT) Solutions: Beyond HIV screening, Singclean will showcase its entire POCT product matrix, including rapid test kits for drugs of abuse, fertility (pregnancy/ovulation), infectious diseases (Flu, Dengue, etc.), and tumor markers.
● Date: July 8th - 10th, 2026
● Venue: Queen Sirikit National Convention Center (QSNCC), Bangkok, Thailand
● Singclean Booth: K23
Innovation-Driven Global Strategy of Singclean Medical
Singclean Medical always adheres to the corporate vision of "improving human health with innovative technology." Backed by continuous R&D investment and a strict quality management system complying with global standards, Singclean has established a robust dual-wheel drive development model:
Absorbable Biomaterials
1. : Singclean holds an industry-leading position in China and continues to capture premium international markets with highly competitive, high-value-added biomaterials.
In Vitro Diagnostics (IVD)
2. : Renowned for its efficient R&D and market agility, Singclean quickly responds to global public health challenges, providing reliable solutions for government procurements and OTC consumer home testing worldwide.
The upcoming joint participation in WHX Miami and WHX Bangkok serves as a major milestone for Singclean's global branding and market localization strategy in 2026.
Singclean Medical warmly welcomes global medical device distributors, healthcare professionals, and clinical experts to visit our booths, experience our innovative clinical solutions, and discuss strategic collaborations!
-
singclean | 2026-05-06
Singclean’s Medical Sodium Hyaluronate Gel for Bone Joint Gained EU MDR CE Certification, Ranking Among First 3 Globally! 协合医疗骨科医用透明质酸钠凝胶成功斩获欧盟MDR CE认证!跻身全球前三!This achievement sets multiple industry records: it is the first MDR CE certificate for hyaluronic acid-based orthopedic products ever issued by DNV worldwide. Singclean Medical has become the first Chinese company to obtain such certification in this category and has successfully ranked among the first 3 companies globally to secure a viscosupplementation MDR CE certificate. This accomplishment underscores Singclean Medical's technological expertise and international competitiveness in the field of orthopedic biomaterials and hyaluronic acid applications. 此次认证创造了多项行业纪录:这是DNV在全球范围内签发的首张透明质酸骨科类MDR CE证书;协合医疗为中国首家获此证书的企业,更成功跻身全球前三。这一成绩,充分彰显了协合医疗在骨科生物医用材料及透明质酸领域的技术积累与国际竞争力。 -
singclean | 2026-05-06
Singclean Medical’s 2nd International Aesthetic Medicine Leadership Summit Concludes Successfully in Shanghai Shanghai, August 27, 2026 – The 2nd International Aesthetic Medicine Leadership Summit, hosted by Singclean Medical, was held at W Shanghai – The Bund, within the IMCAS China Congress venue. Under the theme “Global Vision, Opening a New Chapter,” the summit served as a cross‑border, multi‑disciplinary platform for professional exchange, gathering an impressive lineup of leading physicians and global partners. -
singclean | 2026-05-06
Singclean Medical to Showcase Innovative Aesthetic and Medical Solutions at Dubai Derma 2026 and Medical Fair Asia 2026HANGZHOU, China – Hangzhou Singclean Medical Products Co., Ltd., a leading innovator in absorbable biomaterials and medical aesthetic solutions, has announced its participation in two major international exhibitions in September 2026: Dubai Derma 2026 in the United Arab Emirates and Medical Fair Asia 2026 in Singapore.
